Advocacy intelligence hub — real-time data for patient organizations
Salubris Biotherapeutics Inc — PHASE2
Hummingbird Bioscience — PHASE1, PHASE2
M.D. Anderson Cancer Center — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Lethal congenital contracture syndrome type 2 news →
Global Clinical Leader
Daiichi Sankyo
Sarina A Piha-Paul
M.D. Anderson Cancer Center
📍 Houston, Texas
Victor Moyo, MD, MD
Merrimack Pharmaceuticals
📍 FARMINGTON, CT
View all Lethal congenital contracture syndrome type 2 specialists →